Search concepts
|
Selected Filters
|
- 50 - 75 out of 139 results
Search results
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - Clinical Core
9/15/19 → 6/30/24
Project: Federal Funding Agencies
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Pascual, B., Faridar, A. & Masdeu, J. C.
9/15/19 → 6/30/24
Project: Non Profit
-
-
The Synchrony Program: Specialized Psychiatric Treatment for Special Operations Forces
Madan, A., Fowler, C. & Weinstein, B.
7/1/19 → 6/30/20
Project: State
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
Study of responses to CD44 targeted nanovectors to design a novel adjunctive anti-tuberculosis host-directed therapy
5/15/19 → 3/28/20
Project: Federal Funding Agencies
-
Higher Neural Contribution Underlying Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia Undergoing Bladder Outlet Procedures.
4/1/19 → 7/31/22
Project: Federal Funding Agencies
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Abraham, B. P., Fan, C. & Glassner, K.
2/11/19 → …
Project: Clinical Trial
-
SUPRASPINAL TARGETS IN NEUROGENIC VOIDING DYSFUNCTION
Khavari, R., Boone, T. B., Helekar, S. & Karmonik, C.
8/17/18 → 7/31/22
Project: Federal Funding Agencies
-
Glutathione in Mild Cognitive Impairment
Masdeu, J. C., Faridar, A. & Pascual, B.
8/6/18 → …
Project: Clinical Trial
-
Implantable Nanochannel System for the Controlled Delivery of Osteogenic Growth Peptide
Filgueira, C. S., Grattoni, A. & Weiner, B. K.
8/1/18 → 1/31/21
Project: Federal Funding Agencies
-
-
Corrona Inflammatory Bowel Disease (IBD) Registry
Abraham, B. P., Fan, C. & Glassner, K.
4/3/18 → …
Project: Clinical Trial
-
Role of Brain Inflammation in Alzheimer’s Disease
Masdeu, J. C., Faridar, A., Fujita, M., Nakawah, M. O. & Pascual, B.
2/7/18 → …
Project: Clinical Trial
-
Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy
Baskin, D. S., Butler, E. B. & Teh, B. S.
1/15/18 → …
Project: Clinical Trial
-
Age-related mild cognitive impairment and the protective role of Glutathione: implications for Alzheimerâ??s disease
9/15/17 → 5/31/22
Project: Federal Funding Agencies
-
LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)
Masdeu, J. C., Faridar, A., Nakawah, M. O. & Pascual, B.
9/15/17 → 5/31/24
Project: Non Profit
-
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
3/15/17 → 8/31/23
Project: Federal Funding Agencies
-
NMDA Receptor in Psychosis: Specific Auto-Antibodies
Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B. & Toledo, J. B.
11/14/16 → …
Project: Clinical Trial